LCTX icon

Lineage Cell Therapeutics

118 hedge funds and large institutions have $85.9M invested in Lineage Cell Therapeutics in 2019 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 44 increasing their positions, 20 reducing their positions, and 17 closing their positions.

Holders
118
Holders Change
+13
Holders Change %
+12.38%
% of All Funds
2.56%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
30
Increased
44
Reduced
20
Closed
17
Calls
$98K
Puts
$83K
Net Calls
+$15K
Net Calls Change
-$5K
Name Holding Trade Value Shares
Change
Shares
Change %
US Bancorp
101
US Bancorp
Minnesota
$1K +$1K +487 New
APA
102
American Portfolios Advisors
New York
$18 +$18 +14 New
IA
103
IndexIQ Advisors
New York
-$715K -781,328 Closed
Renaissance Technologies
104
Renaissance Technologies
New York
-$237K -259,300 Closed
ARTA
105
A.R.T. Advisors
New York
-$49K -53,313 Closed
VF
106
Virtu Financial
New York
-$32K -34,884 Closed
Invesco
107
Invesco
Georgia
-$31K -33,796 Closed
PM
108
Pembroke Management
Quebec, Canada
-$23K -25,000 Closed
PP
109
Paloma Partners
Connecticut
-$21K -23,200 Closed
TRCT
110
Tower Research Capital (TRC)
New York
-$21K -22,789 Closed
BDS
111
Banco de Sabadell
Florida
-$19K -20,000 Closed
Millennium Management
112
Millennium Management
New York
-$17K -18,291 Closed
PPA
113
Parametric Portfolio Associates
Washington
-$15K -16,696 Closed
Carson Wealth (CWM LLC)
114
Carson Wealth (CWM LLC)
Nebraska
-$14K -15,200 Closed
SBH
115
Segall Bryant & Hamill
Illinois
-$12K -13,383 Closed
TWA
116
TCI Wealth Advisors
Arizona
-$1K -1,300 Closed